pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
766
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
CALY-002
Eosinophilic Esophagitis
$NVS
NOVARTIS AG
0
catalysts
Phase 1
CAN-10
Hidradenitis Suppurativa
Otsuka Pharmaceutical Co Ltd
0
catalysts
Phase 1
CAP-100
Refractory Chronic Lymphocytic Leukemia (CLL)
Catapult Therapeutics BV
0
catalysts
Phase 1
← prev
page 6 of 26
next →
131
Pain
89
Neurology
1
CB-011
Refractory Multiple Myeloma
DNA-directed RNA polymerase
$CRBU
Caribou Biosciences, Inc.
0
catalysts
Phase 1
CB-06036
Hepatitis B
$GSK
GSK plc
0
catalysts
Phase 1
CB-11
Glioblastoma Multiforme (GBM)
Cellebrain Co Ltd
0
catalysts
Phase 1
CBI-1214
Metastatic Colorectal Cancer
Cartography Biosciences Inc
0
catalysts
Phase 1
CBP-4888
Pre-Eclampsia
Comanche Biopharma Corp
0
catalysts
Phase 1
CC-8464
Erythromelalgia
$PTHS
Pelthos Therapeutics Inc.
0
catalysts
Phase 1
CCAR-066
Diffuse Large B-Cell Lymphoma
Janssen Biotech Inc
0
catalysts
Phase 1
CD38-SADA
B-Cell Non-Hodgkin Lymphoma
Y-mAbs Therapeutics Inc
0
catalysts
Phase 1
CD4LVFOXP3
Unspecified Genetic Disorders
Stanford University
0
catalysts
Phase 1
CDR-404
Head And Neck Squamous Cell Carcinoma (HNSC)
CDR-Life Inc
0
catalysts
Phase 1
CG-P5 peptide
Wet (Neovascular / Exudative) Macular Degeneration
Caregen Co Ltd
0
catalysts
Phase 1
CHECKVacc
Triple-Negative Breast Cancer (TNBC)
Imugene Ltd
0
catalysts
Phase 1
CHF-6795
Chronic Cough
Chiesi Farmaceutici SpA
0
catalysts
Phase 1
CHM-0201
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Chimeric Therapeutics Ltd
0
catalysts
Phase 1
CID-078
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Circle Pharma Inc
0
catalysts
Phase 1
CIN-110
Obesity
CinFina Pharma LLC
0
catalysts
Phase 1
CK-0801
Myelodysplastic Syndrome (Preleukemia)
Cellenkos Inc
0
catalysts
Phase 1
CK-0802
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Cellenkos Inc
0
catalysts
Phase 1
CK-0803
Amyotrophic Lateral Sclerosis
Cellenkos Inc
0
catalysts
Phase 1
CKD-508
Dyslipidemia
Archela Inc
0
catalysts
Phase 1
CLBR-001
B-Cell Chronic Lymphocytic Leukemia
California Institute for Biomedical Research
0
catalysts
Phase 1
CLD-101
Anaplastic Astrocytoma
$CLDI
Calidi Biotherapeutics, Inc.
0
catalysts
Phase 1
CLN-049
Refractory Acute Myeloid Leukemia
$CGEM
Cullinan Therapeutics, Inc.
0
catalysts
Phase 1
CLN-978
Systemic Lupus Erythematosus
$CGEM
Cullinan Therapeutics, Inc.
0
catalysts
Phase 1
CLY-124
Sickle Cell Disease
Cellarity Inc
0
catalysts
Phase 1
CMS-121
Alzheimer's Disease
Virogenics Inc
0
catalysts
Phase 1
CORDStrom
Dystrophic Epidermolysis Bullosa
$INMB
Inmune Bio, Inc.
0
catalysts
